Novabay Pharmaceuticals Stock Price History
NBY Stock | USD 0.07 0.01 12.01% |
If you're considering investing in NovaBay Stock, it is important to understand the factors that can impact its price. As of today, the current price of NovaBay Pharmaceuticals stands at 0.07, as last reported on the 23rd of April, with the highest price reaching 0.09 and the lowest price hitting 0.07 during the day. NovaBay Pharmaceuticals has Sharpe Ratio of -0.16, which conveys that the firm had a -0.16% return per unit of risk over the last 3 months. NovaBay Pharmaceuticals exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify NovaBay Pharmaceuticals' Risk Adjusted Performance of (0.09), standard deviation of 5.98, and Mean Deviation of 4.32 to check out the risk estimate we provide.
NovaBay Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
NovaBay |
Sharpe Ratio = -0.1611
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | NBY |
Estimated Market Risk
5.98 actual daily | 52 52% of assets are less volatile |
Expected Return
-0.96 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
-0.16 actual daily | 0 Most of other assets perform better |
Based on monthly moving average NovaBay Pharmaceuticals is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of NovaBay Pharmaceuticals by adding NovaBay Pharmaceuticals to a well-diversified portfolio.
NovaBay Pharmaceuticals Stock Price History Chart
There are several ways to analyze NovaBay Stock price data. The simplest method is using a basic NovaBay candlestick price chart, which shows NovaBay Pharmaceuticals price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest Price | January 29, 2024 | 0.18 |
Lowest Price | April 22, 2024 | 0.0725 |
NovaBay Pharmaceuticals April 23, 2024 Stock Price Synopsis
Various analyses of NovaBay Pharmaceuticals' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell NovaBay Stock. It can be used to describe the percentage change in the price of NovaBay Pharmaceuticals from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of NovaBay Stock.NovaBay Pharmaceuticals Price Daily Balance Of Power | (0.47) | |
NovaBay Pharmaceuticals Price Rate Of Daily Change | 0.88 | |
NovaBay Pharmaceuticals Price Action Indicator | (0.01) |
NovaBay Pharmaceuticals April 23, 2024 Stock Price Analysis
NovaBay Stock Price History Data
The price series of NovaBay Pharmaceuticals for the period between Wed, Jan 24, 2024 and Tue, Apr 23, 2024 has a statistical range of 0.11 with a coefficient of variation of 21.29. The daily prices for the period are spread out with arithmetic mean of 0.13. The median price for the last 90 days is 0.14. The company underwent 1:35 stock split on 16th of November 2022.Open | High | Low | Close | Volume | ||
04/23/2024 | 0.08 | 0.09 | 0.07 | 0.07 | ||
04/22/2024 | 0.08 | 0.09 | 0.07 | 0.07 | 4,146,227 | |
04/19/2024 | 0.08 | 0.09 | 0.08 | 0.08 | 1,663,539 | |
04/18/2024 | 0.08 | 0.09 | 0.08 | 0.08 | 3,532,078 | |
04/17/2024 | 0.10 | 0.10 | 0.08 | 0.08 | 13,566,712 | |
04/16/2024 | 0.08 | 0.08 | 0.07 | 0.08 | 1,850,525 | |
04/15/2024 | 0.09 | 0.09 | 0.08 | 0.08 | 1,667,907 | |
04/12/2024 | 0.08 | 0.09 | 0.08 | 0.09 | 691,280 | |
04/11/2024 | 0.09 | 0.09 | 0.09 | 0.09 | 1,350,011 | |
04/10/2024 | 0.09 | 0.09 | 0.09 | 0.09 | 1,214,778 | |
04/09/2024 | 0.1 | 0.1 | 0.08 | 0.09 | 2,268,941 | |
04/08/2024 | 0.1 | 0.10 | 0.09 | 0.09 | 2,001,955 | |
04/05/2024 | 0.11 | 0.11 | 0.1 | 0.10 | 1,871,980 | |
04/04/2024 | 0.10 | 0.11 | 0.10 | 0.10 | 2,088,011 | |
04/03/2024 | 0.10 | 0.10 | 0.10 | 0.10 | 1,913,583 | |
04/02/2024 | 0.11 | 0.11 | 0.10 | 0.10 | 1,490,235 | |
04/01/2024 | 0.11 | 0.11 | 0.10 | 0.10 | 1,157,782 | |
03/29/2024 | 0.11 | 0.11 | 0.10 | 0.10 | 2,093,033 | |
03/28/2024 | 0.11 | 0.11 | 0.10 | 0.10 | 2,093,033 | |
03/27/2024 | 0.13 | 0.13 | 0.10 | 0.11 | 7,792,487 | |
03/26/2024 | 0.13 | 0.15 | 0.13 | 0.14 | 11,711,927 | |
03/25/2024 | 0.13 | 0.14 | 0.13 | 0.13 | 2,007,864 | |
03/22/2024 | 0.14 | 0.14 | 0.13 | 0.14 | 484,028 | |
03/21/2024 | 0.14 | 0.14 | 0.14 | 0.14 | 1,012,179 | |
03/20/2024 | 0.14 | 0.14 | 0.14 | 0.14 | 671,188 | |
03/19/2024 | 0.14 | 0.14 | 0.14 | 0.14 | 596,495 | |
03/18/2024 | 0.14 | 0.14 | 0.14 | 0.14 | 997,686 | |
03/15/2024 | 0.13 | 0.14 | 0.13 | 0.14 | 1,004,435 | |
03/14/2024 | 0.15 | 0.15 | 0.13 | 0.13 | 12,426,404 | |
03/13/2024 | 0.14 | 0.15 | 0.14 | 0.14 | 1,053,530 | |
03/12/2024 | 0.14 | 0.14 | 0.14 | 0.14 | 767,604 | |
03/11/2024 | 0.14 | 0.14 | 0.14 | 0.14 | 703,756 | |
03/08/2024 | 0.15 | 0.15 | 0.14 | 0.14 | 733,220 | |
03/07/2024 | 0.14 | 0.14 | 0.14 | 0.14 | 1,002,154 | |
03/06/2024 | 0.15 | 0.15 | 0.14 | 0.14 | 1,594,969 | |
03/05/2024 | 0.15 | 0.16 | 0.15 | 0.15 | 1,434,149 | |
03/04/2024 | 0.16 | 0.16 | 0.15 | 0.15 | 1,427,406 | |
03/01/2024 | 0.15 | 0.15 | 0.15 | 0.15 | 1,091,944 | |
02/29/2024 | 0.15 | 0.15 | 0.14 | 0.15 | 1,346,336 | |
02/28/2024 | 0.14 | 0.16 | 0.14 | 0.15 | 1,788,079 | |
02/27/2024 | 0.15 | 0.15 | 0.14 | 0.14 | 1,656,173 | |
02/26/2024 | 0.15 | 0.16 | 0.14 | 0.15 | 1,537,438 | |
02/23/2024 | 0.15 | 0.16 | 0.15 | 0.15 | 1,194,575 | |
02/22/2024 | 0.15 | 0.15 | 0.14 | 0.15 | 1,544,465 | |
02/21/2024 | 0.16 | 0.16 | 0.15 | 0.15 | 1,743,322 | |
02/20/2024 | 0.17 | 0.17 | 0.15 | 0.16 | 1,988,537 | |
02/16/2024 | 0.16 | 0.17 | 0.15 | 0.17 | 3,152,463 | |
02/15/2024 | 0.15 | 0.16 | 0.14 | 0.16 | 3,455,571 | |
02/14/2024 | 0.14 | 0.16 | 0.14 | 0.15 | 2,146,358 | |
02/13/2024 | 0.14 | 0.14 | 0.13 | 0.14 | 896,287 | |
02/12/2024 | 0.15 | 0.15 | 0.14 | 0.14 | 2,333,755 | |
02/09/2024 | 0.14 | 0.16 | 0.14 | 0.15 | 3,542,134 | |
02/08/2024 | 0.13 | 0.14 | 0.13 | 0.14 | 2,231,049 | |
02/07/2024 | 0.13 | 0.13 | 0.12 | 0.13 | 2,897,355 | |
02/06/2024 | 0.15 | 0.15 | 0.13 | 0.13 | 4,391,447 | |
02/05/2024 | 0.16 | 0.16 | 0.15 | 0.15 | 3,798,946 | |
02/02/2024 | 0.16 | 0.16 | 0.15 | 0.16 | 3,121,184 | |
02/01/2024 | 0.18 | 0.18 | 0.16 | 0.16 | 9,327,061 | |
01/31/2024 | 0.16 | 0.19 | 0.15 | 0.17 | 15,503,852 | |
01/30/2024 | 0.17 | 0.18 | 0.16 | 0.16 | 8,698,162 | |
01/29/2024 | 0.19 | 0.20 | 0.16 | 0.18 | 42,337,445 |
About NovaBay Pharmaceuticals Stock history
NovaBay Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for NovaBay is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in NovaBay Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing NovaBay Pharmaceuticals stock prices may prove useful in developing a viable investing in NovaBay Pharmaceuticals
NovaBay Pharmaceuticals, Inc., a pharmaceutical company, develops and sells eyecare and skincare products in the United States and internationally. NovaBay Pharmaceuticals, Inc. was incorporated in 2000 and is headquartered in Emeryville, California. Novabay Pharmaceuticals operates under Biotechnology classification in the United States and is traded on AMEX Exchange. It employs 29 people.
NovaBay Pharmaceuticals Stock Technical Analysis
NovaBay Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Stock Screener Now
Stock ScreenerFind equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |
All Next | Launch Module |
NovaBay Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for NovaBay Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of NovaBay Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of NovaBay to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | (0.09) | |||
Jensen Alpha | (1.00) | |||
Total Risk Alpha | (1.74) | |||
Treynor Ratio | (2.93) |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in NovaBay Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics. For more information on how to buy NovaBay Stock please use our How to Invest in NovaBay Pharmaceuticals guide.Note that the NovaBay Pharmaceuticals information on this page should be used as a complementary analysis to other NovaBay Pharmaceuticals' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Complementary Tools for NovaBay Stock analysis
When running NovaBay Pharmaceuticals' price analysis, check to measure NovaBay Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NovaBay Pharmaceuticals is operating at the current time. Most of NovaBay Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of NovaBay Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NovaBay Pharmaceuticals' price. Additionally, you may evaluate how the addition of NovaBay Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
CEOs Directory Screen CEOs from public companies around the world | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Transaction History View history of all your transactions and understand their impact on performance |
Is NovaBay Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of NovaBay Pharmaceuticals. If investors know NovaBay will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about NovaBay Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of NovaBay Pharmaceuticals is measured differently than its book value, which is the value of NovaBay that is recorded on the company's balance sheet. Investors also form their own opinion of NovaBay Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is NovaBay Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because NovaBay Pharmaceuticals' market value can be influenced by many factors that don't directly affect NovaBay Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between NovaBay Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if NovaBay Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, NovaBay Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.